Mounjaro maker pauses shipments of weight-loss drug to UK
Eli Lilly, the maker of the weight-loss drug Mounjaro, has temporarily halted shipments of the drug to the UK. This decision comes ahead of a planned price increase of up to 170% for the treatment in the UK starting in September. The move is reportedly part of a White House initiative to encourage pharmaceutical companies to raise drug prices in Europe, which would allow for corresponding price cuts in the United States. This strategy aims to address the disparity in drug prices between the US and European markets. The surge in demand for Mounjaro has prompted Eli Lilly to pause shipments to British wholesalers, as they prepare for the upcoming price hike. This decision is likely to impact the availability of the drug in the UK market until the new pricing structure is implemented.
Source: For the complete article, please visit the original source link below.
